Clene’s FDA up­date; JCR ends ties with Take­da, part­ners with As­traZeneca; Gilead ups stake in Hookipa

Plus, news on Lyn­dra Ther­a­peu­tics, Hadean Cap­i­tal, Barinthus Bio, Shat­tuck Labs and In­ven­ti­va.

Clene Nanomed­i­cine’s road­block: The com­pa­ny, which is de­vel­op­ing a gold nanocrys­tal-based drug …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER